Abiopharma

(99% Neutral) SANA BIOTECHNOLOGY, INC. (SANA) Announces Clinical Development Update

(10% Negative) PACIRA BIOSCIENCES, INC. (PCRX) Announces Delay in million Development Timeline Due to Pandemic-Related Challenges, Manufacturing Considerations, Safety Review, Efficacy Assessment

(10% Negative) Alnylam Pharmaceuticals, Inc. (ALNY) Announces Delay in amyloidosis Trials for adults Due to Pandemic-Related Challenges, Regulatory Process, Safety Review, Efficacy Assessment

(10% Negative) Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) Announces Clinical Development Update (Form 6-K)

(75% Positive) IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Announces Enrollment Update for needs Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(99% Neutral) TALARIS THERAPEUTICS, INC. (TALS) Files Form 8-K

(99% Neutral) Instil Bio, Inc. (TIL) Announces Business Combination

(99% Neutral) Intra-Cellular Therapies, Inc. (ITCI) Announces Regulatory Update

(50% Neutral) ZENTALIS PHARMACEUTICALS, INC. (ZNTL) Announces Regulatory Update

(99% Neutral) CRISPR THERAPEUTICS AG (CRSP) Announces New Board Appointment